- £198.21bn
- £217.54bn
- $54.07bn
- 85
- 16
- 86
- 71
REG - AstraZeneca PLC - Update on AZD7442 STORM CHASER trial
AnnouncementREG - Morgan Stanley & Co. AstraZeneca PLC - Stabilisation Notice
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - BMO Cap & Inc InvTst - Portfolio Update
AnnouncementREG - Stock Exch Notice - Admission to Trading - 03/06/2021
AnnouncementREG - AstraZeneca PLC - Calquence head-to-head results versus ibrutinib
AnnouncementREG - AstraZeneca PLC - Lynparza reduced recurrence risk in breast cancer
AnnouncementREG - AstraZeneca PLC - AstraZeneca appoints new Chief Financial Officer
AnnouncementREG - AstraZeneca PLC - Publication of Final Terms
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Block listing Interim Review
AnnouncementREG - AstraZeneca PLC - Tagrisso approved in EU in early lung cancer
AnnouncementREG - AstraZeneca PLC - Second Price Monitoring Extn
AnnouncementREG - AstraZeneca PLC - Price Monitoring Extension
AnnouncementREG - Schroder UK PublicPT - Announcement of NAV
AnnouncementREG - AstraZeneca PLC - AstraZeneca prices a EUR800m bond offering
AnnouncementREG - Morgan Stanley & Co. AstraZeneca PLC - Stabilisation Notice
AnnouncementREG - AstraZeneca PLC - AstraZeneca prices a $7bn bond offering
AnnouncementREG - Competition and Mkts - Merger Update: AstraZeneca/Alexion
Announcement